干预前后氨曲南的临床应用及安全性评价

    Clinical Application and Safty Assessment of Aztreonam Before and After Intervention

    • 摘要: 目的 通过分析干预前后氨曲南的使用情况,为临床合理用药提供依据。方法 采用回顾性调查方法,对2012年和2013年第2季度笔者所在医院氨曲南的使用情况和不良反应进行分析。结果 干预前有无适应证选药、用法用量错误及联合用药不合理等现象,干预后氨曲南使用基本合理,不良反应发生率为0.67%。结论 氨曲南临床应用干预效果明显,干预后氨曲南应用不合理情况明显降低。

       

      Abstract: OBJECTIVE To analysis the utilization in patients in order to promote rational use of antimicrobial agents before and after intervention. METHODS By retrospective study, the use and ADR of aztreonam in outher’s hospital during April to June period of 2012 and 2013 were analyzed. RESULTS Before intervention, in some cases, the use of aztreonam was irrational in drug choice, dosage, administration and drug combination, etc. After intervention, the use of aztreonam in outher’s hospital was rational, the incidence of ADR was 0.67%. CONCLUSION The intervention on clinical use of aztreonam achieved remarkable outcome, unreasonable use of aztreonam reduced significantly after intervention.

       

    /

    返回文章
    返回